Analyst Price Targets — KRMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 13, 2026 2:09 pm | — | Craig-Hallum | $7.00 | $5.75 | TheFly | Koru Medical price target raised to $7 from $6.25 at Craig-Hallum |
| December 22, 2025 1:43 pm | — | Lake Street | $8.00 | $6.03 | TheFly | Koru Medical price target raised to $8 from $6 at Lake Street |
| December 17, 2025 12:26 pm | — | Canaccord Genuity | $6.00 | $5.77 | TheFly | Koru Medical price target raised to $6 from $5 at Canaccord |
| November 14, 2024 12:19 pm | Matthew O\'Brien | Piper Sandler | $3.50 | $3.10 | StreetInsider | Koru Medical Systems Inc. (KRMD) PT Raised to $3.50 at Piper Sandler |
| July 2, 2024 10:05 am | Kyle Rose | Canaccord Genuity | $3.00 | $2.25 | StreetInsider | Canaccord Genuity Bullish on Koru Medical Systems Inc. (KRMD) |
| January 6, 2023 6:56 am | — | Piper Sandler | $4.50 | $3.70 | Benzinga | Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5 |
| May 5, 2022 4:43 am | Jason Bednar | Piper Sandler | $3.00 | $2.80 | TheFly | Koru Medical investment spend to remain elevated, says Piper Sandler |
Latest News for KRMD
MAHWAH, NJ--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical's management…
Acuitas Investments LLC grew its holdings in KORU Medical Systems, Inc. (NASDAQ: KRMD) by 89.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 763,088 shares of the company's stock after acquiring an additional 360,594 shares during the period. Acuitas
KRMD secures EU MDR certification for its Freedom60 Infusion Pump, opening broader EU access and boosting adoption of patient-friendly home infusion solutions.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that its Freedom60® Infusion Pump, including adapter for use with 50 mL prefilled syringes, has achieved…
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KRMD.
U.S. House Trading
No House trades found for KRMD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.